Bionime Corporation

NT$55.80As of Sun 8 Nov 2026, 12:00 UTC
TWSE:4737Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 6.31%
Div yield —
ROE (14.16%)
Medical Instruments & Supplies
Beta (5Y) (0.22)
PE TTM —
TSR TTM (8.53%)
Mkt cap NT$4.315B
ROIC (7.06%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$63
13.77%
(39.19%)
Hold 12|6|1|4|7
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.62
0.66
0.66
0.63
9.47%
19.52%
10.07%
(3.57%)
RevenueNT$M
376.8
388.7
382.0
382.8
8.24%
14.47%
8.63%
4.77%
Peers (US$130.3M)
Cap (US$)
PE
156.9M
11.85x
107.4M
38.25x
127.8M
—
Capital
TTM
5Y
10Y
Leveragex
1.957
0.726
0.624
EBIT/Intx
1.557
0.426
0.357
Own earn%
(125.24)
29.90
33.37
Sh yield%
28.40
48.47
41.61
Owners
Insiders/Inst%
12.50
32.61
Short interest%
3.27
SBC / revenue%
5.32
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
11–16
$1 testx
—
Incr. ROIC%
1